Phase IB/II Study of Lirilumab with Azacytidine (AZA) in Relapsed AML

Naval Daver; Prajwal Boddu; Guillermo Garcia‐Manero; Farhad Ravandi; Elias Jabbour; Gautam Borthakur; Courtney D. DiNardo; Marina Konopleva; Naveen Pemmaraju; Tapan M. Kadia

doi:10.1182/blood.v130.suppl_1.2634.2634

Phase IB/II Study of Lirilumab with Azacytidine (AZA) in Relapsed AML

NobleID: NI9P99W79R72S65
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/0AC90ABF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0AC90ABF.svg?ark=w1%2F20260515%2F0AC90ABF&value=id)](https://nobleid.org/work/w1/20260515/0AC90ABF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Naval Daver

Prajwal Boddu

Guillermo Garcia‐Manero

Claim authorship of this work

Phase IB/II Study of Lirilumab with Azacytidine (AZA) in Relapsed AML

NobleID: NI9P99W79R72S65
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/0AC90ABF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0AC90ABF.svg?ark=w1%2F20260515%2F0AC90ABF&value=id)](https://nobleid.org/work/w1/20260515/0AC90ABF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Naval Daver

Prajwal Boddu

Guillermo Garcia‐Manero

Claim authorship of this work